- Lobbying
- Lobbying by Halozyme Therapeutics, Inc.
Lobbying Relationship
Bills mentioned
H.R.925: The Heroes Act
Sponsor: Mike Thompson (D-Calif.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Jeff Forbes | Staff Director, Senate Finance Committee, 2003 - 2003; Chief of Staff, Senator Max Baucus, 1999 - 2002; Deputy Director EOP, 1998 - 1999 |
Libby Greer | Chief of Staff, Rep. Allen Boyd, Jun. 2001 - Feb. 2009 |
Jeff Strunk | Deputy Floor Director, House Speaker Boehner, Dec. 2010 - Jan. 2013; Floor Assistant, House Speaker Boehner, Sep. 2007 - Dec. 2010; Legislative Assistant, John Boehner, Apr. 2006 - Dec. 2010; Staff Member, Pat Tiberi, Nov. 2004 - Apr. 2006 |
Derrick White | Deputy Communications Director, Senator Orrin Hatch, 2000 - 2001 |
Kristina Dunklin | Legislative Director, Rep. Brooks, 2018 - 2019; Legislative Director, Rep. Valadao, 2015-2018; Legislative Assistant, Rep. Valadao, 2014-2015 |
Barrett Thornhill | Legislative Assistant, Sen. Mike Crapo (2003-2006); Legislative Assistant, Rep. Pat Toomey (2002-2003) |
Michael Williams | Legislative Director, Rep. Lucy McBath (2021-2022); Legislative Assistant, Rep. Lucy McBath (2019-2020); Legislative Aide, Sen. Doug Jones (2019); Legislative Correspondent, Sen. Doug Jones (2018-2019) |
Edward Reno III | n/a |
Zachary Williams | n/a |
Frank Steinberg | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Q1 Report
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Health & Human Services - Dept of (HHS)
Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Health & Human Services - Dept of (HHS)
Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Health & Human Services - Dept of (HHS)
Centers For Medicare and Medicaid Services (CMS)
Type of Issue
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medicare
Science
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medicare
Science
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medicare
Science
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medicare
Science
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medicare
Science
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medicare
Science
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medicare
Science
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medicare
Science
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medicare
Science
Registration
Issue(s) they said they’d lobby about: Issues related to the coverage of and reimbursement for novel drug delivery system and market uptake/access.
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate